Maf1 suppression of ATF5-dependent mitochondrial unfolded protein response contributes to rapamycin-induced radio-sensitivity in lung cancer cell line A549
- PMID: 33640883
- PMCID: PMC7993702
- DOI: 10.18632/aging.202584
Maf1 suppression of ATF5-dependent mitochondrial unfolded protein response contributes to rapamycin-induced radio-sensitivity in lung cancer cell line A549
Abstract
mTOR is well known to promote tumor growth but its roles in enhancing chemotherapy and radiotherapy have not been well studied. mTOR inhibition by rapamycin can sensitize cancer cells to radiotherapy. Here we show that Maf1 is required for rapamycin to increase radio-sensitivity in A549 lung cancer cells. In response to ionizing radiation (IR), Maf1 is inhibited by Akt-dependent re-phosphorylation, which activates mitochondrial unfolded protein response (UPRmt) through ATF5. Rapamycin suppresses IR-induced Maf1 re-phosphorylation and UPRmt activation in A549 cells, resulting in increased sensitivity to IR-mediated cytotoxicity. Consistently, Maf1 knockdown activates ATF5-transcription of mtHSP70 and HSP60, enhances mitochondrial membrane potential, reduces intracellular ROS levels and dampens rapamycin's effect on increasing IR-mediated cytotoxicity. In addition, Maf1 overexpression suppresses ethidium bromide-induced UPRmt and enhances IR-mediated cytotoxicity. Supporting our cell-based studies, elevated expression of UPRmt makers (mtHSP70 and HSP60) are associated with poor prognosis in patients with lung adenocarcinoma (LAUD). Together, our study reveals a novel role of Maf1-UPRmt axis in mediating rapamycin's enhancing effect on IR sensitivity in A549 lung cancer cells.
Keywords: Maf1; mTOR; mitochondrial unfolded protein response; non-small cell lung cancer cell; radio-resistance.
Conflict of interest statement
Figures





Similar articles
-
A bird's eye view of mitochondrial unfolded protein response in cancer: mechanisms, progression and further applications.Cell Death Dis. 2024 Sep 11;15(9):667. doi: 10.1038/s41419-024-07049-y. Cell Death Dis. 2024. PMID: 39261452 Free PMC article. Review.
-
Cardioprotection by the mitochondrial unfolded protein response requires ATF5.Am J Physiol Heart Circ Physiol. 2019 Aug 1;317(2):H472-H478. doi: 10.1152/ajpheart.00244.2019. Epub 2019 Jul 5. Am J Physiol Heart Circ Physiol. 2019. PMID: 31274354 Free PMC article.
-
UPRmt alleviates bone cancer pain through the restoration of mitochondrial function.Exp Cell Res. 2025 May 15;448(2):114568. doi: 10.1016/j.yexcr.2025.114568. Epub 2025 Apr 22. Exp Cell Res. 2025. PMID: 40273969
-
Noncanonical mitochondrial unfolded protein response impairs placental oxidative phosphorylation in early-onset preeclampsia.Proc Natl Acad Sci U S A. 2019 Sep 3;116(36):18109-18118. doi: 10.1073/pnas.1907548116. Epub 2019 Aug 22. Proc Natl Acad Sci U S A. 2019. PMID: 31439814 Free PMC article.
-
Mitochondrial dysfunction in cancer: Potential roles of ATF5 and the mitochondrial UPR.Semin Cancer Biol. 2017 Dec;47:43-49. doi: 10.1016/j.semcancer.2017.05.002. Epub 2017 May 10. Semin Cancer Biol. 2017. PMID: 28499833 Free PMC article. Review.
Cited by
-
mtUPR Modulation as a Therapeutic Target for Primary and Secondary Mitochondrial Diseases.Int J Mol Sci. 2023 Jan 12;24(2):1482. doi: 10.3390/ijms24021482. Int J Mol Sci. 2023. PMID: 36674998 Free PMC article. Review.
-
Replication Stress: A Review of Novel Targets to Enhance Radiosensitivity-From Bench to Clinic.Front Oncol. 2022 Jul 8;12:838637. doi: 10.3389/fonc.2022.838637. eCollection 2022. Front Oncol. 2022. PMID: 35875060 Free PMC article.
-
A bird's eye view of mitochondrial unfolded protein response in cancer: mechanisms, progression and further applications.Cell Death Dis. 2024 Sep 11;15(9):667. doi: 10.1038/s41419-024-07049-y. Cell Death Dis. 2024. PMID: 39261452 Free PMC article. Review.
-
SIRT3-mediated mitochondrial unfolded protein response weakens breast cancer sensitivity to cisplatin.Genes Genomics. 2021 Dec;43(12):1433-1444. doi: 10.1007/s13258-021-01145-5. Epub 2021 Aug 2. Genes Genomics. 2021. PMID: 34338986
-
Long non-coding RNA CCAT1 acts as an oncogene to promote radiation resistance in lung adenocarcinoma: an epigenomics-based investigation.Funct Integr Genomics. 2024 Mar 7;24(2):52. doi: 10.1007/s10142-024-01330-1. Funct Integr Genomics. 2024. PMID: 38448654
References
-
- Liang SQ, Bührer ED, Berezowska S, Marti TM, Xu D, Froment L, Yang H, Hall SR, Vassella E, Yang Z, Kocher GJ, Amrein MA, Riether C, et al.. mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer. Oncogene. 2019; 38:622–36. 10.1038/s41388-018-0479-6 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous